REQUEST A DEMO
Total
USD $0.00
Search more companies

LAVANDULA PHARMA Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: LAVANDULA PHARMA Bt. Profile Updated: October 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

LAVANDULA PHARMA Bt. is an enterprise in Hungary, with the main office in Bekes. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on August 26, 1994. The total number of employees is currently 10 (2023). In 2024, the company reported a net sales revenue increase of 12.67%. Its’ total assets recorded a negative growth of 5.38%. LAVANDULA PHARMA Bt.’s net profit margin increased by 3.07% in 2024.

Headquarters
Csabai ut.15.sz.
Bekes; Bekes; Postal Code: 5630

Contact Details: Purchase the LAVANDULA PHARMA Bt. report to view the information.

Website: http://www.gondoskodo.hu

Basic Information
Total Employees:
Purchase the LAVANDULA PHARMA Bt. report to view the information.
Registered Capital:
Purchase the LAVANDULA PHARMA Bt. report to view the information.
Financial Auditors:
Purchase the LAVANDULA PHARMA Bt. report to view the information.
Incorporation Date:
August 26, 1994
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after LAVANDULA PHARMA Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.67%
Total Operating Revenue
12.99%
Operating Profit
86.54%
EBITDA
57.67%
Net Profit/Loss for the Period
108.84%
Total Assets
-5.38%
Total Equity
13.53%
Operating Profit Margin
3.04%
Net Profit Margin
3.07%
Return on Equity (ROE)
14.57%
Quick Ratio
245.33%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?